BCHE and dementia: The traditional Alzheimer’s drug armamentarium—cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and the NMDA receptor antagonist memantine—yields, at most, modest and short-lived improvements in cognitive test scores, without a durable reduction in progression to dementia and with a clear excess of adverse events.